CCL5 could significantly promote STAT3 expression, phosphorylation as well as its nuclear translocation in both DU145 and PC3 cells, indicating that CCL5 could induce persistent activation of STAT3 signaling in prostate cancer cells (Fig. 4b, c). Here, STAT3 is linked to prostate carcinoma.